TANEZUMAB

UNII: EQL0E9GCX1
Preferred Substance Name: TANEZUMAB

880266-57-9
IMMUNOGLOBULIN G2, ANTI (HUMAN NERVE GROWTH FACTOR) (HUMAN MOUSE MONOCLONAL RN624 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL RN624 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G2, ANTI (HUMAN NERVE GROWTH FACTOR) (HUMAN MOUSE MONOCLONAL RN624 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL RN624 LIGHT CHAIN, DIMER
PF-4383119
RN624
RN-624
TANEZUMAB [INN]
TANEZUMAB [JAN]
TANEZUMAB [USAN]
TANEZUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

TANEZUMAB

Synonyms and Mappings

Resources

Note